1. Meattini I, Marrazzo L, Saieva C et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial. J Clin Oncol 2020; 38: 4175-4183.
2.
Vicini FA, Cecchini RS, White JR et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet 2019; 394: 2155-2164.
3.
Whelan TJ, Julian JA, Berrang TS et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet 2019; 394: 2165-2172.
4.
Strnad V, Krug D, Sedlmayer F et al. DEGRO practical guideline for partial-breast irradiation. Strahlenther Onkol 2020; 196: 749-763.
5.
Sharma D, Budrukkar A, Kumar R et al. Indian Brachytherapy Society consensus recommendations for brachytherapy in breast cancer. J Contemp Brachytherapy 2024; 16: 257-267.
6.
Witt JS, Gao RW, Sudmeier LJ et al. Low cardiac and left anterior descending coronary artery dose achieved with left-sided multicatheter interstitial-accelerated partial breast irradiation. Brachytherapy 2019; 18: 50-56.
7.
Strnad V, Ott OJ, Hildebrandt G et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 2016; 387: 229-238.
8.
Shaitelman SF, Anderson BM, Arthur DW et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 2024; 14: 112-132.
9.
Mubarak F, Kowkabany G, Popp R et al. Early stage breast cancer: does histologic subtype (ductal vs. lobular) impact 5 year overall survival? Cancers (Basel) 2024; 16: 1509.
10.
Oesterreich S, Nasrazadani A, Zou J et al. Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer. J Natl Cancer Inst 2022; 114: 1511-1522.
11.
Pramod N, Nigam A, Basree M et al. Comprehensive review of molecular mechanisms and clinical features of invasive lobular cancer. Oncologist 2021; 26: e943-e953.
12.
Leonardi MC, Maisonneuve P, Mastropasqua MG et al. Comparison of treatment outcome between invasive lobular and ductal carcinomas in patients receiving partial breast irradiation with intraoperative electrons. Int J Radiat Oncol Biol Phys 2017; 99: 173-181.
13.
Mills MN, Russo NW, Fahey M et al. Increased risk for ipsilateral breast tumor recurrence in invasive lobular carcinoma after accelerated partial breast irradiation brachytherapy. Oncologist 2021; 26: e1931-e1938.
14.
Daniaux M, Gruber L, De Zordo T et al. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI. Eur J Radiol 2023; 163: 110838.
15.
Lobbes MBI, Neeter LMFH, Raat F et al. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer. Eur J Radiol 2023; 164: 110881.
16.
Strnad V, Polgár C, Ott OJ et al. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial. Lancet Oncol 2023; 24: 262-272.
17.
Polgár C, Van Limbergen E, Pötter R et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010; 94: 264-273.
18.
Strnad V, Major T, Polgar C et al. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations. Radiother Oncol 2018; 128: 411-420.
19.
Strnad V, Hannoun-Levi JM, Guinot JL et al. Working Group Breast Cancer of GEC-ESTRO. Recommendations from GEC ESTRO Breast Cancer Working Group (I): Target definition and target delineation for accelerated or boost Partial Breast Irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery. Radiother Oncol 2015; 115: 342-348.
20.
Ott OJ, Hildebrandt G, Pötter R et al. Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. Int J Radiat Oncol Biol Phys 2011; 80: 1458-1463.
21.
Shah C, Wilkinson JB, Shaitelman S et al. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. Int J Radiat Oncol Biol Phys 2011; 81: e547-e551.
22.
Shaikh AY, LaCombe MA, Du H et al. Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-up. Radiat Oncol 2012; 7: 17.
23.
Braunstein LZ, Boe L, Mueller B et al. Accelerated partial breast irradiation for early-stage invasive lobular carcinoma. Int J Radiat Oncol Biol Phys 2025; 121: 894-899.
24.
Polgár C, Gutierrez Miguelez C, Ivanov O et al. Patient selection for APBI: Updated recommendations of the GEC-ESTRO Breast Cancer Working Group based on clinical evidence (2024). Radiother Oncol 2025; 206 (Suppl 1): S170.
